These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 16081028)
21. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330 [TBL] [Abstract][Full Text] [Related]
22. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865 [TBL] [Abstract][Full Text] [Related]
23. Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Hayashi T; Faustman DL Recent Prog Horm Res; 2003; 58():131-53. PubMed ID: 12795417 [TBL] [Abstract][Full Text] [Related]
24. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice. Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586 [TBL] [Abstract][Full Text] [Related]
25. [Current studies on the identification of susceptibility genes for IDDM in NOD mice]. Miyazaki J; Ishii M; Tashiro F Nihon Rinsho; 1994 Oct; 52(10):2772-7. PubMed ID: 7983813 [TBL] [Abstract][Full Text] [Related]
26. Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. Guler ML; Ligons DL; Wang Y; Bianco M; Broman KW; Rose NR J Immunol; 2005 Feb; 174(4):2167-73. PubMed ID: 15699148 [TBL] [Abstract][Full Text] [Related]
27. De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes. Foray AP; Candon S; Hildebrand S; Marquet C; Valette F; Pecquet C; Lemoine S; Langa-Vives F; Dumas M; Hu P; Santamaria P; You S; Lyon S; Scott L; Bu CH; Wang T; Xu D; Moresco EMY; Scazzocchio C; Bach JF; Beutler B; Chatenoud L Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782469 [TBL] [Abstract][Full Text] [Related]
28. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. Goldrath AW; Barber L; Chen KE; Alters SE J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149 [TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress. Mathews CE; Graser RT; Bagley RJ; Caldwell JW; Li R; Churchill GA; Serreze DV; Leiter EH Immunogenetics; 2003 Oct; 55(7):491-6. PubMed ID: 14513297 [TBL] [Abstract][Full Text] [Related]
30. Genetic and immunological basis of autoimmune diabetes in the NOD mouse. Yoshida K; Kikutani H Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686 [TBL] [Abstract][Full Text] [Related]
31. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice. Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281 [TBL] [Abstract][Full Text] [Related]
32. Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice. Lee M; Kim AY; Kang Y J Korean Med Sci; 2000 Apr; 15(2):217-23. PubMed ID: 10803701 [TBL] [Abstract][Full Text] [Related]
33. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis. Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541 [TBL] [Abstract][Full Text] [Related]
34. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system. Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729 [TBL] [Abstract][Full Text] [Related]
35. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247 [TBL] [Abstract][Full Text] [Related]
36. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
37. Idd-linked genetic regulation of TACIhigh expressing B cells in NOD mice. Sundström M; Lejon K J Autoimmun; 2007; 29(2-3):116-24. PubMed ID: 17656068 [TBL] [Abstract][Full Text] [Related]
38. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes. Rojas M; Heuer LS; Zhang W; Chen YG; Ridgway WM Front Immunol; 2022; 13():918837. PubMed ID: 35935980 [TBL] [Abstract][Full Text] [Related]